Clinical trial
A Multi-center, Non-randomized Study to Evaluate the Safety and Effectiveness of the Abre Venous Self-expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction
NCT03038438 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Non-randomized Study to Evaluate the Safety and Effectiveness of the Abre Venous Self-expanding Stent System in Patients With Symptomatic Iliofemoral Venous Outflow Obstruction
- Lead sponsor
- Medtronic Endovascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 13, 2017
- Completion date
- January 28, 2022
- Enrollment
- 260 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
iliofemoral venous obstruction